TrialNeurology(R) neuroimmunology & neuroinflammation2023

Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis.

Stephen L Hauser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.